Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20052
20066
20081
20093
20102
20115
20122
20131
20142
20151
20162
20182
20202
20212
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated11
Recruiting4
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.10
Janssen Research & Development, LLC5
Eli Lilly and Company4
GlaxoSmithKline2
University of Maryland, Baltimore2
Abbott1
AstraZeneca1
Biogen1
Centocor, Inc.1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases41
Crohn Disease22
Colitis, Ulcerative21
Colitis8
Gastrointestinal Diseases6
Colonic Diseases5
Intestinal Diseases5
Ulcer5
Digestive System Diseases4
Gastroenteritis4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.